Abstract
The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.
| Original language | English |
|---|---|
| Pages (from-to) | 3696-3699 |
| Number of pages | 4 |
| Journal | Journal of Clinical Microbiology |
| Volume | 39 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 2001 Oct 22 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
Cite this
}
Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent. / Lee, K.; Lim, J. K.; Yong, D.; Yum, J.; Chong, Y.; Okamoto, R.; Inoue, M.
In: Journal of Clinical Microbiology, Vol. 39, No. 10, 22.10.2001, p. 3696-3699.Research output: Contribution to journal › Article
TY - JOUR
T1 - Evaluation of efficiency of screening extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent
AU - Lee, K.
AU - Lim, J. K.
AU - Yong, D.
AU - Yum, J.
AU - Chong, Y.
AU - Okamoto, R.
AU - Inoue, M.
PY - 2001/10/22
Y1 - 2001/10/22
N2 - The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.
AB - The disk screening methods for extended-spectrum β-lactamase-producing strains were evaluated. The confirmatory work is reduced significantly in settings such as those in this study, by changing the cefpodoxime breakpoint to ≤20 mm and by not testing cefoxitin-resistant isolates. Cefotaxime and ceftazidime disk screening is reliable, and the laboratory-prepared cefotaxime, and ceftazidime-clavulanic acid disks are stable at -20°C for 12 weeks.
UR - http://www.scopus.com/inward/record.url?scp=0034787683&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034787683&partnerID=8YFLogxK
U2 - 10.1128/JCM.39.10.3696-3699.2001
DO - 10.1128/JCM.39.10.3696-3699.2001
M3 - Article
C2 - 11574594
AN - SCOPUS:0034787683
VL - 39
SP - 3696
EP - 3699
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
SN - 0095-1137
IS - 10
ER -